Glucose Modification of Proteins in Diabetic Nephropathy
Glucose Modification of Proteins in Diabetic Nephropathy
批准号:
8211779
负责人:
BILLY GERALD HUDSON
金额:
$1.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-02-16 至 2012-04-30
关键词:
3-deoxyglucosoneAdvanced Glycosylation End ProductsAffectAmericanAnimal ModelApoptosisAtherosclerosisCellsCenters for Disease Control and Prevention (U.S.)ChemicalsChronicClinical ResearchClinical TrialsComplications of Diabetes MellitusDiabetes MellitusDiabetic AngiopathiesDiabetic NephropathyEnd stage renal failureEndothelial CellsEpidemicEpidemiologic StudiesExtracellular MatrixExtracellular Matrix ProteinsFiltrationGenerationsGlucoseHealth Care CostsHyperglycemiaIntegrinsKidneyLigandsLysineModificationNeuropathyPathogenesisPathogenicityPathologyPathway interactionsPlasmaPopulationPost-Translational Protein ProcessingProductionProteinsPyruvaldehydeRetinal DiseasesRoleSeveritiesSourceStressStructureUnited Statesabstractingadductbasecarbonyl compoundcell injurydiabeticdisorder preventionglucose metabolismglycationhuman diseaseinsightkidney cellnoveloxidationpodocyteprotein functionprotein structure function
中文摘要
描述(由申请人提供):
摘要糖尿病是人类的主要疾病之一,现在经常被称为糖尿病流行病。慢性糖尿病会导致严重的并发症,如糖尿病肾病,其特征是肾滤过功能下降,是终末期肾脏疾病的主要原因。一种被广泛接受的假说是,在糖尿病中,高血糖会加速蛋白质的非酶化学修饰(糖基化),扰乱蛋白质功能,导致糖尿病并发症。细胞外基质(ECM)的蛋白质对糖基化非常敏感,因为它们的周转率很低,这允许修饰的积累。蛋白质糖基化的传统观点是葡萄糖直接与蛋白质分子的赖氨酸残基反应,形成Amadori中间体,该中间体经过氧化转化为不同的晚期糖基化终产物(AGE)。近年来,出现了一种新的研究范式,认为高血糖会导致血浆中活性羰基物种(RCs)水平的增加,最突出的是甲基乙二醛(MGO)和3-脱氧葡萄糖苷(3-DG),它们源于葡萄糖和糖化蛋白的氧化降解。这些化合物比葡萄糖更具活性,可以引起更迅速、更广泛的致病蛋白损伤。这一新模式现在得到了许多临床和流行病学研究的支持。然而,RCS产生和致病的机制在很大程度上是未知的。我们取得了一些新的发现,这些发现有助于理解这一新范式的机制,并为这一更新应用确定了方向。这些发现包括:a)发现了葡萄糖自氧化和Amadori中间体氧化产生的新中间体,这对经典的生成MGO和3-DG的机制提出了质疑;以及b)鉴定了由MGO和3-DG引发的细胞-ECM相互作用扰动的新机制。基于这些发现,我们建议1)确定MGO和3-DG产生的新途径;2)确定MGO和3-DG修饰蛋白质的途径;3)确定3)MGO和3-DG或4)MGO和3-DG修饰的ECM如何诱导肾小球细胞损伤。这些目标的完成将为高血糖环境下RCs的生成以及它们如何促进肾小球ECM的结构和功能损害以及细胞与ECM的相互作用提供新的见解,这些相互作用是糖尿病肾病发病的基础。
叙事糖尿病是人类的主要疾病之一。糖尿病的高血糖会导致活性碳基物种(RCS)的增加,这种现象被称为“羰基应激”。我们建议调查糖尿病患者RCS是如何产生的,以及它们是如何导致作为肾脏病理基础的蛋白质和肾细胞损伤的。
英文摘要
DESCRIPTION (provided by applicant):
Abstract Diabetes is one of the major human diseases, now frequently referred to as diabetes epidemic. Chronic diabetes leads to serious complications such as diabetic nephropathy, which is characterized by decline in kidney filtration function and is the leading cause of end-stage renal disease. A widely accepted hypothesis is that in diabetes hyperglycemia accelerates the non- enzymatic chemical modification of proteins (glycation), perturbing protein function and causing diabetic complications. Proteins of extracellular matrix (ECM) are highly susceptible to glycation because of their very low turnover rates, which allow for the accumulation of modifications. The traditional view of protein glycation is that glucose directly reacts with lysine residues of a protein molecule forming an Amadori intermediate that undergoes oxidative conversion to different advanced glycation end products (AGE). In recent years, a new paradigm has emerged with the understanding that hyperglycemia causes increased plasma levels of reactive carbonyl species (RCS), most prominently, methylglyoxal (MGO) and 3-deoxyglucosone (3-DG), derived from oxidative degradation of glucose and glycated proteins. These compounds are much more reactive than glucose and can induce more rapid and more widespread pathogenic protein damage. This new paradigm is now supported by a number of clinical and epidemiological studies. However, the mechanisms underlying RCS generation and pathogenicity are largely unknown. We have made several novel findings which contribute to understanding of the mechanisms of this new paradigm and which set the direction of this renewal application. These include: a) discovery of new intermediates produced from glucose autoxidation and oxidation of Amadori intermediate, which question the classical mechanisms for production of MGO and 3-DG; and b) identification of a novel mechanism of perturbation of cell-ECM interactions triggered by MGO and 3-DG. Based on these findings we propose 1) to define novel pathways of MGO and 3-DG production; 2) to define pathways of protein modification by MGO and 3-DG; to determine how 3) MGO and 3-DG or 4) MGO- and 3-DG- modified ECM can induce glomerular cell injury. The completion of these Aims will provide new insights into how RCS are generated in hyperglycemic milieu and how they may contribute to structural and functional damage of glomerular ECM and to cell-ECM interactions that underlie pathogenesis of diabetic nephropathy.
Narrative Diabetes is one of the major human diseases. Hyperglycemia of diabetes causes increase in reactive carbonyl species (RCS), a phenomenon known as "carbonyl stress". We propose to investigate how RCS are generated in diabetes and how they cause protein and renal cell damage that underlie renal pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Undergraduate Discovery Science Experience in Renal Biology and Disease
-
批准号:10557533
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:8547071
-
项目类别:
-
资助金额:$10.42万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:9317571
-
项目类别:
-
资助金额:$2.51万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Aspirnaut Undergraduate Discovery Science Experience in Renal Biology and Disease
-
批准号:10178002
-
项目类别:
-
资助金额:$10.4万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:9261216
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:9126560
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:8731873
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Aspirnaut Undergraduate Discovery Science Experience in Renal Biology and Disease
-
批准号:9905511
-
项目类别:
-
资助金额:$10.4万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Aspirnaut Undergraduate Discovery Science Experience in Renal Biology and Disease
-
批准号:10391511
-
项目类别:
-
资助金额:$10.4万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:8911565
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:8915143
-
项目类别:
-
资助金额:$1.24万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:8414688
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Undergraduate Research Internships in Pathobiology of Diabetic Nephropathy
-
批准号:9503223
-
项目类别:
-
资助金额:$1.63万
-
财政年份:2012
-
负责人:BILLY GERALD HUDSON
-
依托单位:
2011 Collagen Gordon Research Conferences and Gordon Research Seminar Program
-
批准号:8118330
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Cell-Matrix Interactions in the Glomerulus
-
批准号:7827524
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2009
-
负责人:BILLY GERALD HUDSON
-
依托单位:
2009 Collagen Gordon Research Conferences
-
批准号:7662042
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2009
-
负责人:BILLY GERALD HUDSON
-
依托单位:
DETERMINANTS OF STABILITY AND INTEGRIN BINDING WITHIN COLLAGEN IV NETWORKS
-
批准号:7568442
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2008
-
负责人:BILLY GERALD HUDSON
-
依托单位:
THE ADMINISTRATIVE CORE
-
批准号:7568457
-
项目类别:
-
资助金额:$6.06万
-
财政年份:2008
-
负责人:BILLY GERALD HUDSON
-
依托单位:
2006 American Society for Matrix Biology Meeting
-
批准号:7162043
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2006
-
负责人:BILLY GERALD HUDSON
-
依托单位:
Glucose Modification of Proteins in Diabetic Nephropathy
-
批准号:7464820
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2003
-
负责人:BILLY GERALD HUDSON
-
依托单位:
海外基金